HUP0402671A3 - Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments - Google Patents

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Info

Publication number
HUP0402671A3
HUP0402671A3 HU0402671A HUP0402671A HUP0402671A3 HU P0402671 A3 HUP0402671 A3 HU P0402671A3 HU 0402671 A HU0402671 A HU 0402671A HU P0402671 A HUP0402671 A HU P0402671A HU P0402671 A3 HUP0402671 A3 HU P0402671A3
Authority
HU
Hungary
Prior art keywords
oxadiazol
medicaments
alkoxy
ones
phenyl
Prior art date
Application number
HU0402671A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HUP0402671A2 publication Critical patent/HUP0402671A2/hu
Publication of HUP0402671A3 publication Critical patent/HUP0402671A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
HU0402671A 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments HUP0402671A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
PCT/EP2003/001484 WO2003072555A1 (de) 2002-02-28 2003-02-14 Substituierte 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-one sowie ihre herstellung und verwendung in arzneistoffen

Publications (2)

Publication Number Publication Date
HUP0402671A2 HUP0402671A2 (hu) 2005-04-28
HUP0402671A3 true HUP0402671A3 (en) 2006-07-28

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402671A HUP0402671A3 (en) 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (cg-RX-API-DMAC10.html)
JP (1) JP4486363B2 (cg-RX-API-DMAC10.html)
KR (1) KR20040095240A (cg-RX-API-DMAC10.html)
CN (1) CN1639137A (cg-RX-API-DMAC10.html)
AR (1) AR038701A1 (cg-RX-API-DMAC10.html)
AT (1) ATE557012T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003226977A1 (cg-RX-API-DMAC10.html)
BR (1) BR0307921A (cg-RX-API-DMAC10.html)
CA (1) CA2477031A1 (cg-RX-API-DMAC10.html)
CO (1) CO5611146A2 (cg-RX-API-DMAC10.html)
DE (1) DE10208987A1 (cg-RX-API-DMAC10.html)
HR (1) HRP20040782A2 (cg-RX-API-DMAC10.html)
HU (1) HUP0402671A3 (cg-RX-API-DMAC10.html)
IL (1) IL163683A0 (cg-RX-API-DMAC10.html)
MA (1) MA27172A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA04007960A (cg-RX-API-DMAC10.html)
NO (1) NO20044090L (cg-RX-API-DMAC10.html)
PE (1) PE20030928A1 (cg-RX-API-DMAC10.html)
PL (1) PL370423A1 (cg-RX-API-DMAC10.html)
RU (1) RU2004128933A (cg-RX-API-DMAC10.html)
TW (1) TW200400951A (cg-RX-API-DMAC10.html)
WO (1) WO2003072555A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
RU2007119315A (ru) 2004-10-25 2008-11-27 Зольвай Фармасьютиклз Гмбх (De) Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
BRPI0821482A2 (pt) * 2007-12-27 2015-07-14 Bial Portela & Ca Sa 3-n-fenil-1,3,4-oxadiazolona 5-o-substituída, seu uso, sua composição e seu processo de preparação
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2001066531A1 (de) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one (und) ihre verwendung zur hemmung der hormonsensitiven lipase

Also Published As

Publication number Publication date
EP1480960A1 (de) 2004-12-01
AR038701A1 (es) 2005-01-26
CN1639137A (zh) 2005-07-13
NO20044090L (no) 2004-11-04
PE20030928A1 (es) 2003-12-17
BR0307921A (pt) 2004-12-21
HRP20040782A2 (en) 2005-02-28
CO5611146A2 (es) 2006-02-28
TW200400951A (en) 2004-01-16
JP2005519085A (ja) 2005-06-30
JP4486363B2 (ja) 2010-06-23
DE10208987A1 (de) 2003-09-11
IL163683A0 (en) 2005-12-18
ATE557012T1 (de) 2012-05-15
AU2003226977A1 (en) 2003-09-09
MXPA04007960A (es) 2004-11-26
CA2477031A1 (en) 2003-09-04
WO2003072555A1 (de) 2003-09-04
EP1480960B1 (de) 2012-05-09
PL370423A1 (en) 2005-05-30
MA27172A1 (fr) 2005-01-03
RU2004128933A (ru) 2005-04-20
KR20040095240A (ko) 2004-11-12
HUP0402671A2 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
SI1562946T1 (sl) Novi ksantinski derivati njihova priprava in njihova uporaba kot zdravila
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
PL347500A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
PL344467A1 (en) Substituted indolinones, the production thereof and their use as medicaments
PL345852A1 (en) Benzimidazoles, production thereof and use thereof as medicaments
PL347072A1 (en) Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
HUP0203290A3 (en) Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
PL370423A1 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
MXPA03006580A (es) Amidas de acido carboxilico, su produccion y su uso como medicamentos.
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees